Inventor profile of:

Lars Bode

City:

San Diego, California

Country:

United States

Published Applications:

16

Last publication date:

2025-01-02

Top Assignees for applications by Lars Bode

The entities that hold a legal rights for patent applications filed by inventor Bode Lars:

Recent patent applications by Bode Lars

Lars Bode from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-02
US20250000885A1
Human necessities

COMPOSITION COMPRISING TWO OR MORE OLIGOSACCHARIDES

#2 | 2023-06-29
US20230201228A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#3 | 2023-06-15
US20230181609A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#4 | 2023-05-18
US20230149433A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#5 | 2022-05-12
US20220143056A1
Human necessities

METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES

#6 | 2021-12-16
US20210386765A1
Human necessities

Oligosaccharide as therapeutic agent for alcohol associated liver disease

#7 | 2021-08-05
US20210236527A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#8 | 2021-08-05
US20210236526A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#9 | 2020-07-30
US20200237793A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#10 | 2020-07-23
US20200230161A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#11 | 2019-09-05
US20190269713A1
Human necessities

Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides

#12 | 2017-07-20
US20170204444A9
Chemistry; metallurgy

Chemoenzymatic synthesis of heparin and heparan sulfate analogs

#13 | 2017-01-19
US20170016040A1
Chemistry; metallurgy

CHEMOENZYMATIC SYNTHESIS OF HEPARIN AND HEPARAN SULFATE ANALOGS

#14 | 2014-08-21
US20140235575A1
Chemistry; metallurgy

Chemoenzymatic synthesis of heparin and heparan sulfate analogs

#15 | 2014-03-20
US20140079775A1
Human necessities

AGENTS TO TREAT/PREVENT AMOEBIASIS

#16 | 2013-11-28
US20130315990A1
Human necessities

Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

InventorID:

547366 ⎘